FDA Approves Cerus Anti-Pathogen System For Safer Blood Transfusions
This article was originally published in The Gray Sheet
Executive Summary
The system is meant to proactively kill bacteria and viruses that may otherwise go unnoticed, and has already proven effective in removing dangerous pathogens without increasing risk to patients according to the agency.